Wydler Lab Private Limited - Due diligence report
A 360° intelligence report on Wydler Lab Private Limited: trust score, financial health, credit view, compliance, directors, growth and dist…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Wydler Lab Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsWydler Lab Private Limited is assessed as Low Risk with a Trust Score of 80/100. Wydler Lab Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 11 Aug 2026 from the latest processed filings. Wydler Lab Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 2 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (15.00 Lakh) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Others | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2023 - filings overdue.
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| Subhash Chand | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pratibha Mishra | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Rani Sharma | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Key managerial personnel: Subhash Chand (Whole-time director) · Pratibha Mishra (Managing Director) · Rani Sharma (Whole-time director)
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 95 · Distress 70Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 15.00 Lakh already registered.
- Compliance record supports lending.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 8 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Sai Nirman Pharmaceutical (Opc) Private Limited | U24299PN2021OPC201804 | Shirdi, Maharashtra, India |
| Biogen Laboratories (India) | U24230MH1986PTC039071 | Mumbai, Maharashtra, India |
| Tarag Pharma Private Limited | U24100HR2018PTC076407 | Ambala, Haryana, India |
| Biotech Trading Private Limited | U33110DL2010PTC205689 | Delhi, Delhi, India |
| Balaji Medware Private Limited | U51909DL2017PTC314019 | New Delhi, Delhi, India |
| Prosem Healthcare Private Limited | U51909HR2020PTC091052 | Ambala, Haryana, India |
| Greatline Pharmaceutical Private Limited | U36990UP2020PTC129778 | Chitarkoot, Uttar Pradesh, India |
| Adn Pharmaceuticals Private Limited | U33110MH2009PTC197106 | Pune, Maharashtra, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Wydler Lab Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Wydler Lab Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Wydler Lab Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Wydler Lab Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Wydler Lab Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Wydler Lab Private Limited an active company?
Wydler Lab Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Wydler Lab Private Limited financially healthy?
Wydler Lab Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Wydler Lab Private Limited?
Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Wydler Lab Private Limited?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Wydler Lab Private Limited have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Wydler Lab Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Wydler Lab Private Limited?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.